Joint Corp (NASDAQ:JYNT) Given $5.50 Average Price Target by Brokerages
Joint Corp (NASDAQ:JYNT) has been assigned an average broker rating score of 1.50 (Buy) from the two brokers that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company.
Analysts have set a 12 month consensus price objective of $5.50 for the company and are anticipating that the company will post ($0.20) EPS for the current quarter, according to Zacks. Zacks has also given Joint Corp an industry rank of 65 out of 265 based on the ratings given to its competitors.
A number of research firms have commented on JYNT. Feltl & Co. downgraded shares of Joint Corp from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 24th. Zacks Investment Research raised shares of Joint Corp from a “sell” rating to a “hold” rating in a research report on Tuesday, July 19th. Finally, Maxim Group cut their target price on shares of Joint Corp from $8.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, July 1st.
In other Joint Corp news, CEO Peter D. Holt bought 30,000 shares of the business’s stock in a transaction on Monday, August 29th. The shares were acquired at an average price of $2.66 per share, with a total value of $79,800.00. Following the transaction, the chief executive officer now owns 10,000 shares of the company’s stock, valued at approximately $26,600. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Hedge funds have recently added to or reduced their stakes in the stock. Boston Partners boosted its stake in Joint Corp by 1.1% in the second quarter. Boston Partners now owns 108,550 shares of the company’s stock worth $220,000 after buying an additional 1,170 shares in the last quarter. Skylands Capital LLC boosted its stake in Joint Corp by 12.1% in the second quarter. Skylands Capital LLC now owns 380,734 shares of the company’s stock worth $773,000 after buying an additional 40,950 shares in the last quarter. Emerald Acquisition Ltd. purchased a new stake in Joint Corp during the second quarter worth $108,000. Finally, Sanders Morris Harris Inc. boosted its stake in Joint Corp by 7.0% in the second quarter. Sanders Morris Harris Inc. now owns 2,063,581 shares of the company’s stock worth $4,189,000 after buying an additional 134,753 shares in the last quarter.
Joint Corp (NASDAQ:JYNT) opened at 2.43 on Wednesday. Joint Corp has a 12 month low of $1.85 and a 12 month high of $7.90. The stock’s market cap is $30.94 million. The company has a 50-day moving average of $2.51 and a 200-day moving average of $2.75.
Joint Corp (NASDAQ:JYNT) last posted its quarterly earnings results on Thursday, August 11th. The company reported ($0.26) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.27) by $0.01. The company earned $5 million during the quarter, compared to analysts’ expectations of $3.40 million. On average, equities analysts forecast that Joint Corp will post ($0.97) EPS for the current fiscal year.
Joint Corp Company Profile
The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Joint Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint Corp and related companies with MarketBeat.com's FREE daily email newsletter.